Representative Publications

View All PubMed Entries

Castellani C, Southern KW, Brownlee K, Dankert Roelse J, Duff A, Farrell M, Mehta A, Munck A, Pollitt R, Sermet-Gaudelus I, Wilcken B, Ballmann M, Corbetta C, de Monestrol I, Farrell P, Feilcke M, Férec C, Gartner S, Gaskin K, Hammermann J, Kashirskaya N, Loeber G, Macek M Jr, Mehta G, Reiman A, Rizzotti P, Sammon A, Sands D, Smyth A, Sommerburg O, Torresani T, Travert G, Vernooij A, Elborn S. European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros. 8:153-73, 2009.

Kloosterboer M, Hoffman G, Rock MJ, Gershan W, Laxova A, Li Z, Farrell, PM. Clarification of laboratory variables influencing CF newborn screening with initial analysis of immunoreactive trypsinogen. Pediatr. 123(9): e338-346, 2009.

Lai HC, Shoff SM, Farrell PM and the Wisconsin CF Neonatal Screening Group. Recovery of birth weight z-score within two years of diagnosis is positively associated with pulmonary status at age six years in children with cystic fibrosis. Pediatr. 123: 714-722. 2009.

Rao AR, Laxova A, Farrell PM, and Barbieri JT. Porteomic identification of OprL as a seromarker for the initial diagnosis of Pseudomonas aeruginosa infection of patients with cystic fibrosis. J Clinical Microbiology. 47:2483-8, 2009.

Farrell PM, Collins J, Broderick LS, Rock MJ, Li Z, Kosorok MR, Laxova A, Gershan WM, and Brody AS. Association between mucoid pseudomonas infection and bronchiectasis in children with CF. Radiology. 252:534-43, 2009.

Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, Michel SH, Parad RB, White TB, Farrell PM, Marshall BC, Accurso FJ. Cystic fibrosis foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr. 155:S73-S93, 2009.

Borowitz D, Parad R, Sharp JK, Sabadosa K, Robinson KA, Rock M, Farrell P, Sontag M, Rosenfeld M, Davis S, Marshall B, Accuroso F and other contributors. Cystic fibrosis foundation practice guidelines for the management of infants with CFTR-related metabolic syndrome during the first two years of life and beyond. J Pediatr. 155:S106-S116, 2009.

Hayes D, Farrell PM, Li Z, and West SE. Pseudomonas aeruginosa serological analysis in young children with cystic fibrosis diagnosed through newborn screening. Pediatr Pulmonol. 45:55-61, 2010.

Walsh AC, Rault G, Li Z, Scotet V, Duguépéroux I, Férec C, Roussey M, Laxova A, Farrell PM and the participating CF centres of Brittany, France. Pulmonary outcome differences in U.S. and French cystic fibrosis cohorts diagnosed through newborn screening. J Cyst Fibros. 9:44-50, 2010.